Tumor cells can also evade immune surveillance by binding of programmed cell death ligand-1 (PD-L1), which is expressed on tumor and other cells in the tumor microenvironment, to programmed cell death protein-1 (PD-1) expressed on T cells [29]. The gene discussed is PDCD1; the disease is neoplasm.